Navigation Links
Boston Scientific's SpyGlass® Direct Visualization System Achieves Global Utilization Milestones
Date:5/4/2011

y GI practice and an indispensable technology when performing ERCP procedures," said Douglas Pleskow, M.D., Beth Israel Deaconess Medical Center in Boston.  "It provides excellent direct visual access to the bile ducts and pancreas, helping obtain an accurate diagnosis and deliver effective treatment options in one procedure."

Boston Scientific has completed compatibility testing of the SpyGlass System with the Lumenis® SlimLine GI™ Fiber 365 micron laser probe and the Northgate® EHL probe.  Compatibility with these adjunct technologies allows the system to be used during ERCP for laser or EHL stone ablation procedures within the bile ducts, expanding the product's functional capabilities.

Lumenis and SlimLine GI are trademarks of Lumenis, Ltd.; Northgate is a trademark of Northgate Technologies, Inc.

For more information on the SpyGlass System, visit Boston Scientific's Endoscopy Channel at www.youtube.com/bostonscientificendo.

About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.  

Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forwar
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  New York College of Health Professions announces ... portfolio with U.S. Patent #8,996,098 donated by its Chairman ... a surgical instrument that allows surgeons to view and ... in the traditional format of a slide that is ... during surgery, thus providing the surgeon real time analysis ...
(Date:4/1/2015)... and MOUNTAIN VIEW, Calif. , ... BSX ) announces that it has signed ... venture-backed medical device company that develops, manufactures and ... guided transluminal drainage of targeted areas within the ... this week. The Xlumena portfolio ...
(Date:4/1/2015)... April 1, 2015  The first national study ... supplements to treat attention-deficit/hyperactivity disorder (ADHD) among children ... of children with ADHD were receiving behavioral therapy ... Control and Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity ... published today in The Journal of Pediatrics ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... YORK, Dec. 29, 2010 Reportlinker.com announces that a ... Regenerative Medicine Markets ... way of treating injured and diseased human tissue by ... As such, astounding new advancements in the ability to ...
... 2010 Reportlinker.com announces that a new market ... 2010-2015 In-depth Research Report on China ... Report SummaryBased on the ... General Administration of Custom, Ministry of Commerce , ...
Cached Medicine Technology:Reportlinker Adds Regenerative Medicine Markets 2Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2
(Date:4/1/2015)... South Florida’s newest concept in retirement living, Casa ... from the State of Florida. This approval is ... retirement community that will offer a catered lifestyle designed ... America’s aging population is experiencing unprecedented growth but is ... according to a recent report by Harvard’s Joint Center ...
(Date:4/1/2015)... April 01, 2015 IQ Formulations , ... and nutritional supplement companies in the U.S., today is commending ... and quality control standards for its herbal supplements.* GNC vowed ... chain to ensure the accuracy of labeling on its products. ... and IQ Formulations CEO Jay Cohen said: ...
(Date:4/1/2015)... Dr. Rod J. Rohrich , ... of the Department of Plastic Surgery at UT Southwestern ... reports of blindness resulting from the use of ... published their study, along with ideas for treatment and ... "We began to see increasing reports of blindness as ...
(Date:4/1/2015)... Senior Helpers of Central Texas ... of Choice Award by Home Care Pulse. The Best of ... to home care providers who receive the highest satisfaction scores ... in home care. This recognition reassures you that your home ... you with quality, trustworthy in home care. , In order ...
(Date:4/1/2015)... SkillSurvey, the leading provider of hiring ... and the premiere provider of on-line automated reference checking ... webinar on “Using Big Data to Recruit Millennials.” The ... officer of MorseLife, a nationally recognized provider of health ... families in Palm Beach County. , “As the most ...
Breaking Medicine News(10 mins):Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 2Health News:SkillSurvey Hiring Expert Series Continues with Webinar Featuring MorseLife 3
... risk by 26%, study finds , , TUESDAY, Aug. 5 (HealthDay News) ... you smarter, as your grandmother said, but by lowering the risk ... a new study. , The benefit appears to come from fish ... tuna three times a week can reduce the risk of dementia ...
... May Need a Liver ... Transplant, SACRAMENTO, Calif., Aug. ... she heads to the Mrs.,America* competition in Tucson, Arizona on September 2, she ... Connor will be,healthy again. Connor was born with a deadly liver disease -- ...
... CINCINNATI, Aug. 5 The Procter & Gamble,Company (NYSE: ... the April -,June quarter to $21.3 billion and nine percent ... sales were up five percent for both,the quarter and the ... in which P&G delivered top-line growth at or above the,company,s ...
... Advice to Las Vegas, SCARBOROUGH, N.Y., Aug. 5 ... turning to Bald Girls Do Lunch(R) for cool options,and ... organization,is bringing women with alopecia areata together for the ... The August 15 Las Vegas event is a ...
... aims to give back to Mercy Ships , ... Garden Valley. TX ... of Britain,s greatest medal hopes at the Beijing Olympics, racer Paul Goodison, ... provides free medical care to the people of Africa. , , , ...
... QHR client hospital Gritman Medical Center and its ... Hospital, were recently ranked number one in a ... Services (CMS) in "overall patient satisfaction" in the ... to sharing number one rankings, the hospitals also ...
Cached Medicine News:Health News:Fish May Ward Off Dementia and Stroke 2Health News:Fish May Ward Off Dementia and Stroke 3Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 2Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 3Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 2Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 3Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 4Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 5Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 6Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 7Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 8Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 9Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 10Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 11Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 12Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 13Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 14Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 15Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 16Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 17Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 18Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 19Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 20Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 21Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 22Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 23Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 24Health News:Too Hot for Wigs: Bald Women Go Natural in Nevada 2Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 2Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 3Health News:Olympic Sailing Hopeful Backs Hospital Ship Charity 4Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 2Health News:Collaborative Efforts Prove Effective for QHR Client Hospital Gritman Medical Center and Neighboring Pullman Regional Hospital 3
... an ELISA method for the qualitative detection of ... in human serum. When the EBNA IgG test ... as the EBV viral capsid IgG or IgM, ... the results can serve as an aid in ...
... VCA IgM Test is an ELISA method for ... Virus viral capsid antigen (VCA) in human serum. ... conjunction with other testing such as the EBV ... antigen tests and/or heterophile tests, the results can ...
... ImmunoDOT Borrelia (Lyme) test is ... test for the qualitative detection ... (anti-P39) and related Borrelia burgdorferi ... are detected in serum as ...
... Tests are qualitative enzyme immunoassays (EIA) for ... (IgG or IgM, respectively) in serum. Equivocal ... be supplemented with a standardized western blot ... to support a clinical diagnosis of B. ...
Medicine Products: